Prot #337HNAS20011 (NATiV3): A Randomised, Double‐Blind, Placebo‐Controlled, Multicentre, Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients with Non‐Cirrhotic Non‐Alcoholic Steatohepa

Project: Research project

Project Details

StatusActive
Effective start/end date9/11/239/11/26

Funding

  • Pharmaceutical Research Associates, Inc. (Prot #337HNAS20011 (NATiV3) AMD 2 // Prot #337HNAS20011 (NATi...)
  • Inventiva SAS (Prot #337HNAS20011 (NATiV3) AMD 2 // Prot #337HNAS20011 (NATi...)